InvestorsHub Logo
Followers 664
Posts 46965
Boards Moderated 1
Alias Born 03/30/2009

Re: None

Wednesday, 09/18/2019 9:11:26 AM

Wednesday, September 18, 2019 9:11:26 AM

Post# of 203913
$OWCP 8-K:

Item 8.01 Other Events.



On September 16, 2019, OWC Pharmaceutical Research Corp. (the “Company”) received a Bid Price Deficiency Notice (the “Notice”) from OTC Markets Group that the Company’s bid price had closed below $0.01 for more than 30 consecutive calendar days and thus no longer met the Standards for Continued Eligibility for OTCQB as per the OTCQB Standards Section 2.3(2). The Notice stated that, pursuant to Section 4.1 of the OTCQB Standards, the Company was granted a cure period of 90 calendar days during which the minimum closing bid price for the Company’s common stock must be $0.01 or greater for ten consecutive trading days in order to continue trading on the OTCQB marketplace. If this requirement is not met by December 15, 2019, the Company will be removed from the OTCQB marketplace.



The Company is exploring possible steps to cure the deficiency.


https://ih.advfn.com/stock-market/USOTC/owc-pharmaceutical-research-OWCP/stock-news/80753700/current-report-filing-8-k

Success is never final; failure is never fatal. It's courage that counts.--John Wooden (1910-2010)

Courage is being scared to death, but saddling up anyway.--John Wayne (1907-1979)